ACHV

Achieve Life Sciences, Inc. - Common Shares (ACHV)

About Achieve Life Sciences, Inc. - Common Shares (ACHV)

Achieve Life Sciences, Inc. is a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence. Its products include cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Bothell, WA.

Details

Daily high

$8.07

Daily low

$7.82

Price at open

$8.05

52 Week High

$8.64

52 Week Low

$2.62

Market cap

821.2M

Dividend yield

Volume

520,901

Avg. volume

1.6M

P/E ratio

-5.15

Achieve Life Sciences, Inc. - Common Shares News